Hyperlipidemia

ISSN 1662-4009 (online)

An indispensable reference tool endorsed by the European Society for Paediatric Endocrinology

Previous issue | Volume 19 | ESPEYB19 | Next issue

Yearbook of Paediatric Endocrinology 2022

12. Type 2 Diabetes, Metabolic Syndrome and Lipids

Previous section
Metabolic syndrome

Table of contents

ey0019.12-11 | Hyperlipidemia

12.11. Identification and evaluation of a lipid-lowering small compound in preclinical models and in a Phase I trial

ey0019.12-12 | Hyperlipidemia

12.12. Childhood hypertriglyceridemia: is it time for a new approach?

ey0019.12-13 | Hyperlipidemia

12.13. Vaccine targeting ANGPTL3 ameliorates dyslipidemia and associated diseases in mouse models of obese dyslipidemia and familial hypercholesterolemia

ey0019.12-14 | Hyperlipidemia

12.14. Maternal hypercholesterolaemia during pregnancy affects severity of myocardial infarction in young adults

ey0019.12-15 | Hyperlipidemia

12.15. Awareness, diagnosis and treatment of heterozygous familial hypercholesterolemia (HeFH) Results of a US national survey

ey0019.12-16 | Hyperlipidemia

12.16. Biased Outcome reporting Guidelines for Underwhelming Studies (BOGUS) statement and checklist

ESPE Yearbook of Paediatric Endocrinology
ISSN 1662-4009 (Online)
© Bioscientifica 2025 | Privacy policy | Cookie settings

Bioscientifica Abstracts is the gateway to a series of products that provide a permanent, citable record of abstracts for biomedical and life science conferences.

Find out more

ESPE Yearbook of Paediatric Endocrinology